Latest kidney cancer Stories
SAN DIEGO, May 2, 2011 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced that it has signed an exclusive agreement with WILEX AG for commercialization rights in the United States for RENCAREXÂ® (girentuximab).
The number of cases of idiopathic pulmonary fibrosis (IPF) has continued to rise significantly in the first decade of the 21st century and could lead to more deaths than ovarian cancer, lymphoma, leukaemia, or kidney cancer, reveals research published ahead of print in the Thorax journal.
Researchers at UT Southwestern Medical Center have discovered genetic pathways to starve selectively kidney cancer cells.
Patients with kidney cancer who had their entire organ removed were more likely to have more renal complications and poorer health after surgery, compared to those who had only part of their kidney removed, a study has shown.
70,000 members of the Kidney Cancer Association will join cancer survivors from more than 100 nations for a first-ever World Cancer Day Facebook Group Chat Evanston, IL (PRWEB) January 31, 2011 On World Cancer Day, February 4, 2011, members of the Kidney Cancer Association (KCA), the world's largest patient-led kidney cancer organization, invites survivors and their families and friends to join a 24-hour-long live Facebook chat.
Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus.
NEW YORK, Nov. 19, 2010 /PRNewswire-FirstCall/ -- Pfizer Inc.
Scientists are calling for more research on the possibility that some supposedly healthful plant-based antioxidants â€” including those renowned for their apparent ability to prevent cancer â€” may actually aggravate or even cause cancer in some individuals.
SAN DIEGO, Oct. 11 /PRNewswire/ -- More than 120 cancer survivors and caregivers, cancer-treating physicians, and patient advocates gathered in San Diego to share their ProleukinÂ® (aldesleukin for injection) treatment experiences.
LAS VEGAS, Oct.